Results 31 to 40 of about 3,923 (195)
Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase inhibitor used for the management of difficult-to-treat Gram-negative infections.
Rossella Barone +6 more
doaj +1 more source
Due to the fact that there is a steadily increasing trend in the area of antimicrobial resistance in microorganisms, there is a need to look for new treatment alternatives.
Anna Duda-Madej +2 more
doaj +1 more source
Aim: Meropenem–vaborbactam and delafloxacin activities were not assessed against Achromobacter spp. (Achr), Burkholderia cepacia complex (Bcc) and Stenotrophomonas maltophilia (Smal). Methodology: A total of 106 Achr, 57 Bcc and 100 Smal were tested with
Thomas Guillard (12633958) +11 more
core +1 more source
The role of β-lactamases in reduced susceptibility or resistance to cefiderocol has been supported by recent reports. The purpose of this study was to investigate the in vitro impact of clinically available β-lactamase inhibitors on cefiderocol activity ...
Gabriele Bianco +7 more
doaj +1 more source
The rate of change in SYPRO orange fluorescence is plotted versus temperature for PBP3 in the presence of varying concentrations of vaborbactam. Duplicate measured Tm values are as follows: PBP3 (with DMSO): 47.2 and 47.8°C; PBP3 with 0.5 mM vaborbactam (
Vijay Kumar (377076) +5 more
core +1 more source
Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
The growing emergence of drug-resistant bacterial strains is an issue to treat severe infections, and many efforts have identified new pharmacological agents.
Giacomo Luci +3 more
doaj +1 more source
Aim: Infections by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae represent a major challenge because of limited treatment strategies. New β-lactam/β-lactamase inhibitor associations may help to deal with this challenge.
Romanelli, Federica +15 more
core +1 more source
Aim: Meropenem–vaborbactam and delafloxacin activities were not assessed against Achromobacter spp. (Achr), Burkholderia cepacia complex (Bcc) and Stenotrophomonas maltophilia (Smal). Methodology: A total of 106 Achr, 57 Bcc and 100 Smal were tested with
Thomas Guillard (12633958) +11 more
core +1 more source
A, simplified diagram of the crystal structure of PBP3 complexed to vaborbactam. The catalytic domain is colored grey; the N-terminal domain is in green. Vaborbactam is depicted in spheres with the carbon atoms in cyan.
Vijay Kumar (377076) +5 more
core +1 more source
METHOD DEVELOPMENT AND VALIDATION FOR MEROPENEMAND VABORBACTAM BY RP-HPLC METHOD
A simple, Accurate, precise method was developed for the simultaneous estimation of the Meropenem and Vaborbactam in Tablet dosage form. Chromatogram was run through Inertsil ODS C185mm (4.6 x 250mm).
D.Vaishnavi, Dr V.Kiran Kumar
core +1 more source

